Maverick Simulation Solutions

Healthcare & Pharmaceuticals

Unlisted

Current Price

₹2375

52W Low

₹1249

▲ 5.2% this month

- 3.2% this month

52W High

₹1965

Market Cap

₹3,290.9 Cr

▲ 5.2% this month

- 3.2% this month

Price Performance

Historical indicative price trend

Key Financials

Revenue (TTM)

₹136.3 Cr

Net Profit

₹47.82 Cr

EBITDA

₹64.16

EPS

₹97.32

ROE

78.03%

ROCE

59.34%

Debt / Equity

0.23

Book Value

Face Value

About

Maverick Simulation Solutions

Founded

2006

Headquarters

Dwarka, New Delhi, India

Employees

Listed (IPO)

Unlisted

Maverick Simulation Solutions is an Indian medical simulation and healthcare training technology company, engaged in designing and manufacturing advanced simulation systems for medical colleges, hospitals, and healthcare institutions. Its portfolio includes high-fidelity simulators, skill trainers, and turnkey simulation lab solutions, supporting competency-based clinical education and patient safety training.

The company operates a technology-driven, asset-light model, with strategic focus on innovation, cost-efficient production, and simulation-based learning aligned with evolving medical accreditation standards. Performance is closely linked to growth in medical education capacity, healthcare infrastructure spending, and institutional procurement cycles. Headquartered in New Delhi, India, Maverick primarily serves domestic institutions while exploring selective export opportunities within the expanding healthcare training ecosystem.

Shareholders

Name

2026

Promoter

78.74%

Others

21.26%

Promoter and Management

Designation

Experience

Mr. Anuj Chahal

Director

NA

Ms. Kanika Chahal

Director

NA

Particulars

FY23

FY24

FY25

FY26

Total Revenue

-

14.44

138.86 Total Revenue YoY Growth (%)

-

861.63 EBITDA

-

1.42

64.16 EBITDA Margin (%)

-

9.98

47.07 EBIT

-

1.4

64.13 EBIT Margin (%)

-

9.84

47.05 PBT

-

1.26

61.3 PBT Margin (%)

-

8.86

44.97 PAT

-

0.94

47.82 Revenue from Operations

-

14.22

136.3 YoY Growth (%)

-

2363.79

EPS (Diluted ₹)

-

3.95

97.32 Particulars

FY23

FY24

FY25

FY26

Total Non-Current Assets

-

8.83

7.56 -

Total Current Assets

-

78.33

155.88 -

Total Assets

-

87.17

163.44 -

Total Non-Current Liabilities

-

0

17.07 -

Total Current Liabilities

-

61.6

55.37 -

Total Liabilities

-

61.6

72.44 -

Total Equity

-

25.56

97 -

Total Liabilities and Equity

-

87.17

163.44 -

Particulars

FY23

FY24

FY25

FY26

Cash & Cash Equivalents (Closing)

-

3.57

7.24 -

Operating Activities (A)

-

-20.39

-21

-

Investing Activities (B)

-

-8.34

-11.29

-

Financing Activities (C)

-

32.31

35.96 -

Net (Decrease) / Increase (A+B+C)

-

3.58

3.67 -

Particulars

FY23

FY24

FY25

FY26

Current Ratio (x)

-

1.27

2.81 -

Cashflow Ratio (x)

-

-0.33

-0.37

-

EBIT Margin (%)

-

9.84

47.05 Net Profit Margin (%)

-

6.61

35.08 -

ROA (%)

-

1.07

38.16 -

ROE (%)

-

3.67

78.03 -

ROCE (%)

-

5.47

59.34 -

Operating Profit Margin (%)

-

9.84

47.05 -

PBT Margin (%)

-

8.86

44.97 EBITDA Margin (%)

-

9.98

47.07 Debt to Equity (x)

-

2.41

0.23 -

Get More Information

Fill in your details and our team will reach out shortly.

Quick Snapshot

ISIN

INE218H01017

CIN

₹10

Industry

Financial Services

Lot Size

50 Shares

Dipository:

NSDL & CDSL

PAN No.

CCRCM2519C

Registration Date

10/06/2006

Why Choose GrowFast

Your trusted partner in unlisted shares investment discovery

Verified & Transparent Data

Every company listing on Grow Fast undergoes manual verification. We display only accurate, up-to-date information — no inflated numbers, no misleading claims.

Curated for Serious Explorers

We handpick companies that meet our quality bar. Our team monitors each listing regularly so you're always looking at credible, relevant opportunities.

Zero Clutter. Pure Information

No push to buy. No noise. Grow Fast is built purely to inform — so you can research, compare, and decide at your own pace with zero pressure.

Ready to Explore Unlisted Opportunities?

Join thousands of informed investors who trust GrowFast for their unlisted
shares research

Blogs & News